Introduction {#S0001}
============

Chronic constipation is one of the most common pediatric healthcare problems worldwide, with an estimated prevalence ranging between 0.7% and 29.6% in both developed and developing countries. It is estimated that constipation in children causes 3 −5% of visits to pediatric physicians and up to 25% of referrals to children gastroenterologists worldwide.[@CIT0001] Although constipation may have several etiologies, in more than 90% to 95% of children, no underlying pathological cause can be identified and is described as functional constipation. Functional constipation is typically characterized by the painful passage of hard and/or large stools, abdominal pain, and fecal incontinence, which causes a significant impact on the child and family, as well as considerable effects on health-related quality of life.[@CIT0002] Functional constipation diagnosis is based on the Rome criteria for gastrointestinal functional disorders, currently, the Rome IV criteria.[@CIT0003] The large intestine is a natural reservoir for many different microorganisms. It is possible that alteration in gut flora an etiologic factor in the pathogenesis of functional bowel disorders in pediatrics. However, very few studies are available on the causal relationship between functional constipation and microbiome composition in children suffering from constipation.[@CIT0004] It is believed that colonic microflora, especially lactobacilli, can play a beneficial role in the prevention of constipation through several mechanisms such as producing lactic acid, acetic acid, and other acids, stimulating intestinal peristalsis, as well as increasing fecal bolus moisture.[@CIT0005] Based on this hypothesis, to evaluate which of the major *Lactobacillus* species might be useful in preventing functional constipation, determine phylogenetic diversity and the quantity of this flora in the intestine is pivotal.[@CIT0006] The present study was aimed to evaluate the quantities of the main seven *Lactobacillus* species in the stool samples of constipated children compared with healthy controls using quantitative real-time PCR (qPCR).

Materials and Methods {#S0002}
=====================

Ethical Consideration {#S0002-S2001}
---------------------

This study protocol was conducted in accordance with the Declaration of Helsinki and approved by the Ethical Committee of Ahvaz Jundishapur University of Medical Sciences, Iran (No. IR.AJUMS.REC.1397.433). Written informed consent was obtained by the parents of the participants.

Subjects and Sample Collection {#S0002-S2002}
------------------------------

The case--control study comprised 40 children with functional constipation and 40 normal healthy children without any gastroenterological problems as a control group. The criteria for enrolling the study were aged 4 to 18 years and suffering from functional constipation, according to the criteria of ROME IV (for at least 2 months), which were examined and approved by a pediatrician. Exclusion criteria were history of long-term use of antispasmodic drugs, receiving of any oral laxative 4 weeks ago, consumption of antibiotics or probiotics within 15 days prior to enrollment, a diagnosis of metabolic and gastrointestinal diseases (such as hypothyroidism, inflammatory bowel disease and celiac disease), neurological conditions (such as Hirschsprung's disease and spinal cord abnormalities), mental retardation, anorectal pathology and previous intestinal surgery. In addition, similar exclusion criteria were fulfilled by controls as the study group. The project was explained by clinical researchers to all recruited subjects and informed consent was obtained from the children's parents or legal guardians.

All study subjects and controls were selected by a pediatric gastroenterologist and asked to provide information on demographic characteristics, medical history, current defection pattern, existence or absence of avoidance, stool incontinence, family history of constipation, frequency of abdominal pain per week, severity of constipation, duration of symptoms of constipation, no response to constipation treatment, and use of probiotics and other medication. Fecal samples were freshly collected from all the participants in a sterile plastic container at the hospital or at home and immediately refrigerated at 4 °C until transported to the laboratory, where the containers were stored frozen at −80 °C until DNA extraction.

Reference Strains {#S0002-S2003}
-----------------

Seven *Lactobacillus* reference strains (*L. casei* ATCC 39392, *L. paracasei* ATCC 25598, *L. rhamnosus* ATCC 7469, *L. plantarum* ATCC 8014, *L. reuteri* ATCC 23272, *L. fermentum* ATCC 9338, *L. acidophilus* ATCC 4356) used to validate the assays in the study were ordered from the Iranian Research Organization for Science and Technology (IROST, Iran). All strains were grown in MRS broth under microaerophilic conditions at 37°C for 24 h.

DNA Extraction from Fecal Samples {#S0002-S2004}
---------------------------------

Bacterial DNA from frozen fecal samples was extracted using a QIAamp DNA stool mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions with some modifications. Prior to the kit protocol, the equivalent volume to 1 g of fecal material homogenized in ice water and centrifuged at 1000 × g for 1 min to remove large particles and debris. About 300 mg of supernatants was transferred to a new tube and 200 μL of TE buffer (Tris-HCl \[10mM\]: EDTA 10 mM\], lysozyme \[20mg/mL\]; pH 8.0) was added. The tubes were then vortexed for 1 min and incubated at 37° C for1 h. The protocol was then continued as the manufacturer (Qiagen, Hilden, Germany) described. In addition, because the target microorganisms were Gram-positive, to improve the bacterial cell rupture, the lysis temperature was increased to 95°C. Finally, total genomic DNA was stored at −20 °C until use. NanoDrop One spectrophotometer (Thermo Scientific, Wilmington, DE, USA) was used to quantify DNA extracted by different methods, and the quality of the extracted DNA was estimated at 260 and 280 nm from the absorbance ratio.

Oligonucleotide Primers {#S0002-S2005}
-----------------------

The specifications of oligonucleotide primers for the detection of lactobacilli are listed in [Table 1](#T0001){ref-type="table"}.[@CIT0007]--[@CIT0011] A new specific primer pair was designed for amplification and detection of *L. casei* using an alignment of 16S-23S intergenic spacer region and obtained with the primer3 online software tool ([<http://bioinfo.ut.ee/primer3-0.4.0/>]{.ul}). The sequences were retrieved from the GenBank database ([<http://www.ncbi.nlm.nih.gov>]{.ul}) and aligned using multiple sequence alignment with Molecular Evolutionary Genetics Analysis (MEGA) software V 6. The oligonucleotide primers were synthesized by Sinaclon Company (Sinaclon, Tehran, Iran). The specificity of *L. casei* primer pair was initially evaluated in silico using the BLAST (Basic Local Alignment Search Tool) database search program ([<http://www.ncbi.nlm.nih.gov/BLAST>]{.ul}). The specificity was subsequently confirmed by conventional and quantitative PCR assays using DNA extracted from pure cultures of 21 lactobacilli and non-lactobacilli strains obtained from the Iranian Research Organization for Science and Technology (IROST, Iran) as a control ([Table 2](#T0002){ref-type="table"}). The specificity of Primers for the other *Lactobacillus* species assays has been previously tested. However, once again their specificity was checked in silico by performing BLAST searches of the Gene Bank database.Table 1List of Primers Used in This StudySpecificityPrimersSequence (5ʹ→3ʹ)Annealing\
T (°C)Amplicon\
Length (bp)Target GeneGenome\
Copy NumberReference*L. casei*LcasF\
LcasRTTTGAGGGGACGACCCTCAAGCA\
CGCCGACAAGCTATGAATTCACTTG5533916S-23S spacer region3Our study*L. paracasei*PC2a\
CPRrevGGATTGGGTTTTGCGTGATGGTCGC\
TGCATTTCCCCGCTTTCATGACT68261*mutL*17*L. rhamnosus*LrhamF\
LrhamRGGACAGGTAGAAAGTCAAACGA\
GCTGACCGTAAACGCAATCTTAG65186*mutL*18*L. plantarum*Lp-F\
Lp-RAAAATCATGCGTGCGGGTAC\
ATGTTGCGTTGGCTTCGTCT55210*pyrG*19*L. reuteri*Lreu-1\
Lreu-4CAGACAATCTTTGATTGTTTAG\
GCTTGTTGGTTTGGGCTCTTC6030516S-23S spacer region610*L. acidophilus*LacidoF\
LacidoRTGCAAAGTGGTAGCGTAAGC CCTTTCCCTCACGGTACTG4720716S-23S spacer region411*L. fermentum*Lfer-3\
Lfer-4ACTAACTTGACTGATCTACGA\
TTCACTGCTCAAGTAATCATC5019116S-23S spacer region511 Table 2Specificity of the *L. Casei* Primer Pair Used in This StudyStrainOriginSpecificityConventional PCRQuantitative PCR*Lactobacillus casei*ATCC 39392++*Lactobacillus paracasei*ATCC 25598----*Lactobacillus rhamnosus*PTCC 1637----*Lactobacillus plantarum*PTCC 1058----*Lactobacillus reuteri*PTCC 1655----*Lactobacillus fermentum*PTCC 1638----*Lactobacillus acidophilus*PTCC 1643----*Bifidobacterium bifidum*PTCC 1644----*Bifidobacterium breve*ATCC 15700----*Bifidobacterium longum*ATCC 15707----*Bifidobacterium animalis*PTCC 1631----*Escherichia coli*PTCC 1330----*Salmonella typhi*PTCC 1609----*Salmonella enterica*PTCC 1709----*Shigella flexneri*PTCC 1865----*Listeria monocytogenes*PTCC 1783----*Enterobacter aerogenes*PTCC 1221----*Clostridium difficile*ATCC 9689----*Staphylococcus aureus*PTCC 1189----*Bacillus cereus*PTCC 1015----*Enterococcus faecalis*PTCC 1778----*Pseudomonas aeruginosa*PTCC 1074----

Standard Curves for qPCR {#S0002-S2006}
------------------------

In order to verify the sensitivity of the test and compare the real-time PCR outputs with the bacterial colony-forming units (CFU) acquired with the plating, standard curves were constructed by plotting the threshold cycles (C~t~) values against the log input extracted DNA from respective reference strains. Briefly, bacterial suspension was grown in 5 mL of MRS broth to an OD 600 nm of 0.6 (Nanodrop One, Thermo Scientific, Wilmington, DE, USA) and serially diluted to a final concentration range of 10^1^--10^7^ CFU mL^−1^. A 100 µL of each dilution was plated on MRS agar and incubated under the microaerophilic condition for 48h at 37°C. Colonies were then enumerated and used for colony-forming unit extrapolation (CFU per milliliter). All experiments were performed at least in triplicate and the average titer (CFU mL-^1^) of three replicates was determined. For spiking, fresh fecal samples were from three healthy volunteers initially examined for the absence of the investigated *Lactobacillus* species by both bacteriological and conventional PCR methods. An ﻿amount of 500 μL of each bacterial dilution was spiked into 200 μL of fecal homogenates to make final concentrations (10^1^--10^7^ CFU/g) of feces. Community DNA from spiked feces was extracted using a QIAamp DNA stool mini kit (Qiagen, Hilden, Germany) as described above. By comparing the C~t~ values acquired to the standard curve, the number of cells of lactobacilli in the fecal samples was determined. For each dilution, average C~t~ values (from triplicates) and standard deviations (SD) were calculated. As previously described,[@CIT0012] the total number of bacteria (CFU) was interpolated from the average standard curves. When qPCR was conducted in unknown fecal samples, these standard curves were used to determine the quantity of the lactobacilli population.

The reliability criteria of standard curves were verified by the amplification efficiency (*E*) and the correlation coefficient (*R2*). The amplification efficiency (*E*) was calculated by using the slope of the line derived from the standard curves and the equation *E* = 10 (−1/slope) −1, where b is the slope of the linear fit (eg, *E* = 1 or 100%). In an acceptable reaction, when the efficiency is 100%, the slope will generate −3.32. The correlation coefficient (*R2*) obtained for each standard curve is a measure of how well the data fit in a straight line and should be less than 0.99. The detection limit was defined as the lowest concentration presenting a positive threshold cycle (Ct) value in the standard curves at which linearity was retained. The coefficients of variation (CV%) within each triplex qPCR assay were determined for DNA extracts from three fecal samples spiked with different cell numbers of each seven reference strains. The procedure was performed five times to determine inter-assay reproducibility and three times in triplicate for Intra-assay repeatability.

Quantitative Real-Time PCR {#S0002-S2007}
--------------------------

Real-time quantitative PCR was performed using genus and species-specific primer sets ([Table 1](#T0001){ref-type="table"}), to measure the quantity of the total *Lactobacillus* and the quantity of each of the seven *Lactobacillus* species detected by conventional PCR in each fecal sample. Amplifications were carried out in an ABI StepOne (Applied Biosystems, USA), according to the protocol previously described with a few modifications.[@CIT0013] Briefly, the reaction was performed in a final volume of 25 μL containing 10 μL SYBR Green PCR Master mix 2X (Ampliqon, Denmark), 5 μL nuclease-free water, 2 μL template DNA, and 1 μL (10 pmol μL−1) of each forward and reverse primer. Amplification consisted of 1 min pre-incubation at 95 °C (hot start), followed by 40 cycles with 1 min at 95 °C, 15 s at 60 °C and 30 s at 72 °C. Amplifications were measured in triplicate. Bacterial DNA of reference strains was composed in all qPCR plates as positive control while PCR mixture solution without community DNA was used as the negative control. To determine the specificity of the PCR reactions, post-amplification melting curve analyses were performed automatically by slowly increasing the temperature from 60°C - 98°C (ramp rate 0.11 °C/s), with continuous fluorescence collection. The qPCR amplified amplicon was finally confirmed by using 2.5% agarose gel electrophoresis. In addition, qPCR products were sequenced in 10% of all isolates. Results were analyzed using Sequence Detection Software version 2.1, supplied by Applied Biosystems.

Statistical Analysis {#S0002-S2008}
--------------------

Shapiro--Wilk test was used to investigate the normal distribution of quantitative variables. In the case of a normal distribution, independent *t*-test, and in the absence of normal distribution, the non-parametric Mann--Whitney *U*-test or Kruskal--Wallis test was used. One-way ANOVA was performed to detect significant differences among the *Lactobacillus* species. Chi-square test and Fisher's exact test were used to analyze the qualitative variables. The software used is SPSS version 24.0 (SPSS Inc., Chicago, IL, USA), Microsoft Office Excel version 2016 and GraphPad Prism version 8 (GraphPad Software, Inc). Statistical significance was considered *P-value* \<0.05 in all tests. Diversity of species in both groups of volunteers was measured using the Shannon index.

Results {#S0003}
=======

Demographic and Clinical Symptoms {#S0003-S2001}
---------------------------------

In total 80 children (40 functional constipation and 40 healthy controls) participated in the study. Patients with functional constipation (diagnosed using Rome IV criteria, n = 40) and healthy controls (n = 40) were comparable in age (mean 8.1±3.1 years vs 8.1±3.2 years) and gender (23/40 \[57.5\] vs 19/40 \[47.5\] female). In this study, no statistically significant differences were found between the study population in the findings at presentation, gender (P = 0.950), and age (P = 0.925) distribution. The most commonly observed symptoms among the symptoms of presentation in the patients were (in descending order), painful defecation (92.5%), abdominal pain (90%), and fecal retention (87.5%). In the last three months before incorporation, four healthy children recorded abdominal pain; however, none of these children met the Rome IV criteria. Demographic and Clinical Symptoms of both study groups are displayed in [Table 3](#T0003){ref-type="table"}.Table 3Demographic and Clinical Characteristics of the SubjectsParametersControls (40) N (%)Constipated Children (40) N (%)Total N (%)*P*-valueSex0.370\* Female19 (47.5)23 (57.5)42(52.5) Male21 (52.5)17 (42.5)38(47.5)Age (months)^◊^8.1±3.28.1±3.10.950^£^Abdominal pain\<0.001^€^ Yes3(7.5)36(90)39(48.8) No37(92.5)4(10)41(51.3)History of Hard Bowel Movement Yes-28(70)28(70) No-12(30)12(30)Fecal Incontinence Yes-29(72.5)29(72.5) No-11(27.5)11(27.5)History of Fecal Retention Yes-35(87.5)35(87.5) No-5(12.5)5(12.5)Duration of constipation (months)-7.4 ± 2.8Family history of constipation\<0.001\* Yes14(35)32(80)46(57.5) No26(65)8(20)34(42.5)Painful Defecation Yes-37(92.5)37(92.5) No-3(7.5)3(7.5)[^1]

The Specificity of the Primers {#S0003-S2002}
------------------------------

The results of the analysis for the specificity of the *L. casei* primer pair used in this study, as well as the results obtained by testing the various strains with the conventional and quantitative PCR procedure, are shown in [Table 2](#T0002){ref-type="table"}. The results showed high specificity of the designed primer set for the detection of *L. casei*. The sizes of the amplicon generated by conventional PCR were 339 bp. All DNA samples from non-target strains tested with *L. casei* primer showed no amplification during conventional PCR and no increase in fluorescence during real-time PCR. The specificity of primers for the other *Lactobacillus* species was tested by submitting each oligonucleotide sequence to the Gene Bank database, and the results demonstrated that no mismatches with the rest of the analyzed microorganisms.

Standard Curves and Limit of Detection {#S0003-S2003}
--------------------------------------

Standard curves for the quantification of *Lactobacillus* species were constructed from 10-fold serial dilutions of genomic DNA extracted from each of seven reference strains. A highly linear correlation between the Ct values and the quantity of each species (CFU/mL) was obtained for different standard curves with coefficients of determination (*R*2 values) ranged from 0.995 to 1.000 ([Figure 1](#F0001){ref-type="fig"}). According to the run, the amplification efficiencies for seven intended species were from 97.9% to 102.9%. The detection limit was considered as the lowest concentration at which linearity of the standard curves was preserved. The coefficients of variation of inter-assay reproducibility and intra-assay repeatability, as well as detection limits of the different specific real-time PCR procedures (ranged from 2.84 to 3.86 CFU/gr feces), are shown in [Table 4](#T0004){ref-type="table"}. Based on Ct values, the reproducibility of qPCR assays was found to be very high, indicating that qPCR assays were accurate and that the DNA extraction method was highly reproducible.Figure 1Representative standard curves obtained by plotting the average Ct values against the estimated log10 CFU/PCR for *L. casei* (**A**), *L paracasei* (**B**), *L rhamnosus* (**C**), *L fermentum* (**D**), *L acidophilus* (**E**), *L plantarum* (**F**) *and L. reuteri* (**G**).Table 4Intra-Assay Repeatability, Inter-Assay Reproducibility and Detection Limits of qPCRTargetQuantities (log~10~ CFU/gram)Intra-Assay Repeatability (Ct)Inter-Assay Reproducibility (Ct)Detection Limit (log~10~ CFU/g feces)MeanSDCV %MeanSDCV %*L. plantarum*4.7519.570.060.3119.550.020.103.86*L. paracasei*4.3622.490.040.1822.490.020.093.75*L. rhamnosus*4.3122.650.050.2222.610.020.093.77*L. reuteri*4.6322.890.020.0922.900.020.092.84*L. casei*4.3922.470.020.0922.480.020.093.80*L. fermentum*4.6721.440.040.1921.450.020.093.00*L. acidophilus*4.2122.920.050.2222.940.020.093.43[^2]

Quantification of Lactobacilli in Feces {#S0003-S2004}
---------------------------------------

Differences in the *Lactobacillus* composition in healthy subjects' stool samples compared with those found in the constipated patients' fecal microbiota were assessed using species-specific qPCR. In the present study, seven different *Lactobacillus* species were detected in the feces of constipated and non-constipated children. Each of the twenty-five constipated patients positive for lactobacilli (out of forty) only had one detectable *Lactobacillus* species, whereas all forty healthy patients were positive for lactobacilli and five had two distinct *Lactobacillus* species present. According to the species-specific qPCR results, *L. paracasei* (30%) followed by *L. plantarum* (25%) had the highest prevalence among all species isolated from both patient and healthy groups ([Table 5](#T0005){ref-type="table"}). The diversity index (Shannon H score) of fecal *Lactobacillus* species in constipated children was higher in compared with healthy controls (1.81 versus 1.72, *p \< 0.001*). In all samples containing lactobacilli, the average quantity of seven *Lactobacillus* species was ranged between 6.95 and 6.01 (Log~10~ CFU/gram of feces) and 4.71--2.61 (Log~10~ CFU/gram of feces) for non-constipated and constipated children, respectively ([Table 6](#T0006){ref-type="table"}). In addition, except for *L. casei*, there was a significant difference in the amount of six other species (Log~10~ CFU/gram of feces) between the constipated patients and healthy controls (*p \< 0.05*) ([Figure 2](#F0002){ref-type="fig"}). As shown in [Table 6](#T0006){ref-type="table"}, the amount of *L. casei* in the stool of healthy subjects was also significantly higher than constipated children (mean 6.55±0.01 log~10~ CFU/gram of feces versus mean 3.77±0.13 log~10~ CFU/gram of farces), but because of the low sample size, the difference was not statistically significant (*p \<0.2*). Higher amounts of *L. fermentum* and *L. reuteri* (mean 10^6.95^ and 10^6.91^ CFU/gram feces, respectively) were detected in fecal samples of the healthy subjects than other species. In contrast, the population quantity of *L. reuteri* (mean 10^2.61^ CFU/gram feces) was lower in constipated patients compared with other species. These results showed there was a significant difference in quantity (Log~10~ CFU/gram feces) between *Lactobacillus* species in constipated children and healthy controls (p \< 0.0001) ([Figure 2](#F0002){ref-type="fig"}, [Table 6](#T0006){ref-type="table"}).Figure 2Quantity of seven *Lactobacillus* species in the feces of constipated children and healthy controls. Statistical significance of observed differences in the amount of *Lactobacillus* species between both constipated and healthy groups was measured by the Mann--Whitney *U*-test. Bars represent standard errors. P \< 0.05 was marked with one asterisk (∗), and P \< 0.2 with two asterisks (∗∗). One-way ANOVA testing shows the significant differences in quantity (log~10~ CFU/gram) between *Lactobacillus* species.Table 5Prevalence of *Lactobacillus* Species, Detected by Quantitative PCRSpeciesPrevalence n (%) by qPCRNon Constipated N (%)Constipated N (%)Total\
N (%)*L. plantarum*10 (12.5)10 (12.5)20 (25)*L. paracasei*13 (16.2)11 (13.7)24 (30)*L. rhamnosus*6 (7.5)5 (6.2)11 (13.7)*L. reuteri*3 (3.7)4 (5)7 (8.7)*L. casei*2 (2.5)3 (3.7)5 (6.2)*L. fermentum*3 (3.7)3 (3.7)6 (7.5)*L. acidophilus*3 (3.7)4 (5)7 (8.7) Table 6The Quantity of Fecal Lactobacilli in Constipated Children and Healthy ControlsSpeciesHealthy ControlsConstipated Children\*P-valueQuantities (log CFU/gram) Max MinRangeMeanSDQuantities (log CFU/gram) Max MinRangeMeanSD*L. palntarum*6.395.480.926.010.334.854.310.544.550.19\<0.0001*L. paracasei*6.425.490.926.070.305.123.991.124.450.34\<0.0001*L. rhamnosus*6.395.960.436.250.154.934.500.434.710.17\<0.0043*L. reuteri*6.986.820.166.910.083.172.840.982.610.48\<0.0001*L. fermentum*7.026.900.116.950.063.583.270.303.460.16\<0.0001*L. casei*6.566.540.016.550.013.883.620.263.770.13\<0.2*L. acidophilus*6.516.250.256.350.133.583.400.183.490.09\<0.0001[^3][^4]

Discussion {#S0004}
==========

Growing evidence indicates that alterations in the gut microbiota composition are associated with the pathophysiology of several gastrointestinal disorders such as chronic constipation. Lactobacilli as an essential part of healthy gastrointestinal microecology attracts considerable interest among gastrointestinal researchers in recent years. Thus far, several randomized controlled trials have been conducted on the use of lactobacilli for the management of chronic constipation;[@CIT0006] however, the amount of intestinal lactobacilli in functional constipation are yet poorly investigated, especially in children. The overall aim of our study was to determine the quantitative difference between seven fecal *Lactobacillus* populations of constipated children and nonconstipated controls.

Following the development of culture-independent methods, it has been found that the numbers of autochthonous *Lactobacillus* were approximately 1% of the total bacterial inhabitants in the human colon. Furthermore, specific species *Lactobacillus* that persists in the intestines of some individuals, in others undetectable or representing transient alterations in composition.[@CIT0014] Among over 50 *Lactobacillus* species that were detected in the stools of healthy individuals, *L. acidophilus, L. salivarius, L. casei, L. plantarum, L. fermentum, L. reuteri, L. rhamnosus, L paracasei* and *L. brevis* are the most commonly isolated species. In this study, we focused on the intended seven *Lactobacillus* species because they were previously described as members of the fecal microbiota of healthy humans.[@CIT0015]--[@CIT0018] Furthermore, several clinical trials have shown that they were effective in treating a variety of gastrointestinal disorders, such as functional constipation.[@CIT0006]

Recently, many investigators have used the SYBR green qPCR technique to detect different bacterial species in stool samples.[@CIT0013],[@CIT0019] In this study, we used species-specific qPCR primers to investigate some predominant *Lactobacillus* species colonizing the gut of both healthy and patient volunteers. As previously reported,[@CIT0020] we detected lactobacilli in 65 (81%) of the fecal samples by the culture and conventional PCR methods, and in all samples by quantitative PCR, which indicates the higher diagnostic ability of the qPCR technique than the other two methods in complex samples. So far, only three studies have described the gut microbiome composition in children with functional constipation. In a culture-based methods study, Zoppi et al showed that lactobacilli were significantly decreased in the fecal samples of constipated children as compared with healthy controls.[@CIT0021] In another study, Moraes et al used real-time quantitative PCR to demonstrate that constipated patients had a significantly lower level of lactobacilli than non-constipated children.[@CIT0022] Similar to these findings, based on the quantitative real-time PCR analysis, we observed a significant decreased in the population of lactobacilli in constipated patients' stool samples compared to healthy controls (p \< 0.0001). Contrarily, Zhu et al using 16S rRNA gene pyrosequencing technique demonstrated that the lactobacilli have not decreased in the microbiomes of the constipated obese children.[@CIT0023] Differences between our findings and those from the Zhu et al study may be due to obese subjects' specific phenotype, as obesity is associated with particular intestinal microbiota composition.

Interestingly, based on the quantitative real-time PCR method, it was found that *Lactobacillus acidophilus* was present in amounts very close to its detection limit in constipated children's feces (10^3.43^ CFU/g of feces). So, it can be deduced that the mere presence of different species of *Lactobacillus* in the colon is not sufficient to impact and prevent certain diseases such as functional constipation and their amount plays a decisive role. Our data showed a significantly lower amount of all species in constipated patients compared to healthy controls. Nevertheless, in the case of *L. casei*, because of the low sample size, the P-value could not accurately be measured and therefore the results were not statistically significant (P \< 0.2).

Although the major intestinal *Lactobacillus* species were detected in our study, the bacterial coverage was still incomplete, and we did not examine other probiotic bacteria especially bifidobacteria. Furthermore, this work did not assess the metabolic activities of intended *Lactobacillus* strains. These are the main limitations of our study, and hence further studies on healthy and patient subjects should be able to elucidate the clinical significance of colonizing with these genera, as well as the influence of *Lactobacillus* species metabolic activities in context to functional constipation.

Another limitation is that we used SYBR green-based qPCR for the quantitative determination of seven *Lactobacillus* species rather than more sophisticated techniques such as shotgun metagenome sequencing analysis. However, qPCR is also very sensitive, specific, and cost-effective method that has been successfully used to quantify probiotic microorganisms in complex bacterial ecosystems such as stool samples.[@CIT0013],[@CIT0024]--[@CIT0026]

Conclusion {#S0005}
==========

Our study shows that quantitative real-time PCR assay is a simple, rapid, sensitive, and specific method for strain-specific identification of *Lactobacillus* species from stool samples without prior DNA purification. This study is valuable not only because it showed the quantitative difference in the lactobacilli flora of patients with functional constipation vs healthy subjects, but also because it is one of the few studies that has been performed on the intestinal *Lactobacillus* flora in children with this age range. Moreover, this is the first study that has been conducted on the number of various *Lactobacillus* species in children with functional constipation.
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